Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Atsushi Kaneko »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Atsushi Imai < Atsushi Kaneko < Atsushi Kawakami  Facettes :

List of bibliographic references indexed by Atsushi Kaneko

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
001B46 (2016) Toshihisa Kojima [Japon] ; Nobunori Takahashi ; Koji Funahashi ; Shuji Asai ; Kenya Terabe ; Atsushi Kaneko [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Takeshi Oguchi [Japon] ; Hideki Takagi [Japon] ; Yasuhide Kanayama [Japon] ; Yuichiro Yabe [Japon] ; Tsuyoshi Watanabe [Japon] ; Takayoshi Fujibayashi [Japon] ; Tomone Shioura [Japon] ; Takayasu Ito [Japon] ; Yutaka Yoshioka [Japon] ; Hisato Ishikawa [Japon] ; Nobuyuki Asai ; Toki Takemoto ; Masayo Kojima [Japon] ; Naoki IshiguroImproved safety of biologic therapy for rheumatoid arthritis over the 8-year period since implementation in Japan: long-term results from a multicenter observational cohort study.
002003 (2015) Toshihisa Kojima [Japon] ; Yuichiro Yabe [Japon] ; Atsushi Kaneko [Japon] ; Nobunori Takahashi [Japon] ; Koji Funahashi [Japon] ; Daizo Kato [Japon] ; Masahiro Hanabayashi [Japon] ; Shuji Asai [Japon] ; Shinya Hirabara [Japon] ; Nobuyuki Asai [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Masayo Kojima [Japon] ; Naoki Ishiguro [Japon]Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
002057 (2015) Tomonori Kobayakawa ; Toshihisa Kojima ; Nobunori Takahashi ; Masatoshi Hayashi ; Yuichiro Yabe ; Atsushi Kaneko ; Tomone Shioura ; Kiwamu Saito ; Yuji Hirano ; Yasuhide Kanayama ; Hiroyuki Miyake ; Nobuyuki Asai ; Koji Funahashi ; Shinya Hirabara ; Masahiro Hanabayashi ; Shuji Asai ; Naoki IshiguroDrug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors for rheumatoid arthritis in Japanese patients on low-dose methotrexate or without methotrexate.
002481 (2014) Shinya Hirabara [Japon] ; Nobunori Takahashi ; Naoki Fukaya ; Hiroyuki Miyake ; Yuichiro Yabe ; Atsushi Kaneko ; Takayasu Ito ; Takeshi Oguchi ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Fumiaki Sugiura ; Masatoshi Hayashi ; Koji Funahashi ; Masahiro Hanabayashi ; Shuji Asai ; Naoki Ishiguro ; Toshihisa KojimaClinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
002482 (2014) Nobunori Takahashi [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Yuichiro Yabe ; Hideki Takagi ; Takeshi Oguchi ; Hiroyuki Miyake ; Takefumi Kato ; Naoki Fukaya ; Hisato Ishikawa ; Masatoshi Hayashi ; Seiji Tsuboi ; Yasuhide Kanayama ; Daizo Kato ; Koji Funahashi ; Hiroyuki Matsubara ; Yosuke Hattori ; Masahiro Hanabayashi ; Shinya Hirabara ; Kenya Terabe ; Yutaka Yoshioka ; Naoki IshiguroClinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
002674 (2013) Atsushi Kaneko [Japon]Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy.
002743 (2013) Toshihisa Kojima [Japon] ; Yuichiro Yabe ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Masatoshi Hayashi ; Hiroyuki Miyake ; Hideki Takagi ; Takefumi Kato ; Kenya Terabe ; Tsuyoshi Wanatabe ; Hiroki Tsuchiya ; Daihei Kida ; Tomone Shioura ; Koji Funahashi ; Daizo Kato ; Hiroyuki Matsubara ; Nobunori Takahashi ; Yosuke Hattori ; Nobuyuki Asai ; Naoki IshiguroMonitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
002819 (2013) Shigeki Momohara [Japon] ; Jun Hashimoto ; Hideki Tsuboi ; Hisaaki Miyahara ; Natsuko Nakagawa ; Atsushi Kaneko ; Naoki Kondo ; Hiroaki Matsuno ; Takahiko Wada ; Tohgo Nonaka ; Katsuaki Kanbe ; Haruki Takagi ; Akira Murasawa ; Tsukasa Matsubara ; Toru SuguroAnalysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.
002826 (2013) Yuichiro Yabe [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Nobuyuki Asai ; Tomonori Kobayakawa ; Naoki IshiguroA review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study.
003456 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Takeshi Oguchi ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Takayasu Ito ; Kenya Terabe ; Naoki Fukaya ; Yasuhide Kanayama ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Takayoshi Fujibayashi ; Masayo Kojima ; Naoki IshiguroStudy protocol of a multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study.
003469 (2012) Shunsuke Mori [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Akio Mimori ; Norihiro Nishimoto ; Sadatomo Tasaka ; Kazuhiro Hatta ; Hidekazu Matsushima ; Shunji Kaise ; Atsushi Kaneko ; Shigeki Makino ; Seiji Minota ; Takashi Yamada ; Shinobu Akagawa ; Atsuyuki KurashimaRadiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.
003520 (2012) Toshihisa Kojima [Japon] ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Hiroyuki Miyake ; Hideki Takagi ; Yuichiro Yabe ; Takefumi Kato ; Kenya Terabe ; Naoki Fukaya ; Hiroki Tsuchiya ; Tomone Shioura ; Koji Funahashi ; Masatoshi Hayashi ; Daizo Kato ; Hiroyuki Matsubara ; Naoki IshiguroEarly aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice.
003A57 (2011) Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
003B10 (2011) Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon]Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Atsushi Kaneko" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Atsushi Kaneko" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Atsushi Kaneko
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021